List of articles with "Lund"

Asgard Adds Cancer Leaders

Asgard Adds Cancer Leaders

Sweden Cancer Immunotherapy Lund Asgard Therapeutics AT-108
Safeture and Amadeus Partner

Safeture and Amadeus Partner

Sweden Lund Safeture Travel Risk Management Amadeus
Imlifidase for GBS Insights

Imlifidase for GBS Insights

Sweden Lund Hansa Biopharma imlifidase GBS Treatment
Safeture & Amadeus Partnership

Safeture & Amadeus Partnership

Sweden Lund Safeture Amadeus Cytric
Imlifidase in GBS Treatment

Imlifidase in GBS Treatment

Sweden Lund Hansa Biopharma imlifidase Guillain-Barré
New COO at Hansa

New COO at Hansa

Sweden Lund Hansa Biopharma IDEFIRIX Maria Törnsén
Törnsén Joins Hansa

Törnsén Joins Hansa

USA Lund Hansa Biopharma IDEFIRIX Maria Törnsén
Tropical Storm Trends

Tropical Storm Trends

Sweden Climate Change Lund Safeture Hurricane Season
2025 Hurricane Season Report

2025 Hurricane Season Report

Sweden Lund Riskline Hurricane Season Safeture AB
BPC Instruments 2024 Report

BPC Instruments 2024 Report

Sweden biotechnology Lund Annual Report BPC Instruments
BPC Instruments Q1 Report

BPC Instruments Q1 Report

Sweden Lund BPC Instruments DairyExperts Jing Liu
BPC Instruments Q1 Results

BPC Instruments Q1 Results

Sweden Lund BPC Instruments Q1 2025 DairyExperts
TFS & Oncomatryx Trial

TFS & Oncomatryx Trial

USA Lund TFS HealthScience Oncomatryx OMTX705
TFS and Oncomatryx Study

TFS and Oncomatryx Study

Sweden Lund TFS HealthScience Oncomatryx OMTX705
TFS & Oncomatryx Trials

TFS & Oncomatryx Trials

USA Lund TFS HealthScience Oncomatryx OMTX705
TFS and Oncomatryx's Focus

TFS and Oncomatryx's Focus

USA Lund TFS HealthScience Oncomatryx OMTX705
TFS and Oncomatryx's New Trial

TFS and Oncomatryx's New Trial

USA Lund pancreatic cancer TFS HealthScience Oncomatryx
Enhanced Travel Risk Maps

Enhanced Travel Risk Maps

Sweden Lund Travel Safety Safeture Risk Maps
Safeture's New Risk Maps

Safeture's New Risk Maps

Sweden Lund Travel Safety Safeture Risk Maps
Alfa Laval Meeting Highlights

Alfa Laval Meeting Highlights

Sweden investment strategy Lund Alfa Laval Annual Meeting
Alfa Laval Q1 Results

Alfa Laval Q1 Results

Sweden Lund Alfa Laval financial report Q1 2025
Enzymatica Q1 2025 Highlights

Enzymatica Q1 2025 Highlights

Sweden Lund ColdZyme Enzymatica
Oczyesa® Acromegaly Advances

Oczyesa® Acromegaly Advances

Sweden Lund Camurus Oczyesa Acromegaly
Oczyesa® Approved in EU

Oczyesa® Approved in EU

Sweden Lund Camurus Oczyesa CHMP
Hansa Biopharma Q1 Results

Hansa Biopharma Q1 Results

Sweden financial results Lund Hansa Biopharma IDEFIRIX
Hansa Biopharma Q1 Results

Hansa Biopharma Q1 Results

Sweden Lund Hansa Biopharma IDEFIRIX HNSA-5487
Immunovia Warrant News

Immunovia Warrant News

Sweden Immunovia Lund Warrants TO 3
Asgard's New CDO

Asgard's New CDO

Sweden Lund Asgard Therapeutics Shane Olwill AT-108
Miriam Martin's New Role

Miriam Martin's New Role

USA Lund Clinical Development TFS HealthScience Miriam Martin
Immunovia's Test Success

Immunovia's Test Success

Sweden Immunovia Lund pancreatic cancer VERIFI study
Hansa Biopharma Reports

Hansa Biopharma Reports

Sustainability Sweden Lund Hansa Biopharma IDEFIRIX
Hansa's 2024 Reports

Hansa's 2024 Reports

Sweden Lund Hansa Biopharma IDEFIRIX HNSA-5487
Immunovia Webcast on VERIFI Study

Immunovia Webcast on VERIFI Study

Sweden Immunovia Lund VERIFI PancreaticCancer
Alfa Laval Acquires Fives

Alfa Laval Acquires Fives

Sweden Lund Alfa Laval Fives Group Cryogenics
Immunovia's Validation Success

Immunovia's Validation Success

Sweden Immunovia Lund pancreatic cancer VERIFI study
Alfa Laval's Ammonia Contract

Alfa Laval's Ammonia Contract

Sweden Lund Alfa Laval Maritime Industry Ammonia Fuel
Hansa Biopharma Phase 3 Study

Hansa Biopharma Phase 3 Study

Sweden Lund kidney transplant Hansa Biopharma IDEFIRIX
Hansa Biopharma Phase 3

Hansa Biopharma Phase 3

Sweden Lund kidney transplant Hansa Biopharma IDEFIRIX
Immunovia's CLARITI Presentation

Immunovia's CLARITI Presentation

Sweden Immunovia Lund pancreatic cancer CLARITI study
InCoax's $1 Million Deal

InCoax's $1 Million Deal

Sweden Lund fiber networks InCoax Networks MoCA Access
InCoax MoCA Order

InCoax MoCA Order

Sweden Lund InCoax Networks broadband solutions MoCA Access
BPC Instruments 2024 Results

BPC Instruments 2024 Results

Sweden Renewable Energy Lund Environmental Technology BPC Instruments
Leadership Update at TFS

Leadership Update at TFS

Sweden Lund TFS HealthScience Katarina Ageborg Markus Granlund
TFS Leadership Changes

TFS Leadership Changes

USA Lund TFS HealthScience Katarina Ageborg Markus Granlund
Immunovia 2024 Results

Immunovia 2024 Results

Sweden Immunovia Lund pancreatic cancer diagnostics
TFS Leadership Transition

TFS Leadership Transition

USA Lund TFS HealthScience Katarina Ageborg Markus Granlund
TFS HealthScience Leadership Change

TFS HealthScience Leadership Change

Sweden Lund TFS HealthScience Katarina Ageborg Markus Granlund
TFS HealthScience Leadership Changes

TFS HealthScience Leadership Changes

Sweden Lund TFS HealthScience Katarina Ageborg Markus Granlund
BPC Instruments Order

BPC Instruments Order

Sweden Lund BPC Instruments DairyExperts Gas Endeavour III
InCoax Expands Network

InCoax Expands Network

Sweden Lund InCoax Networks MoCA Access broadband service

【About Using Articles】

You can freely use the title and article content by linking to the page where the article is posted.
※ Images cannot be used.

【About Links】

Links are free to use.